Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Slaps Replidyne With Faropenem Warning

Feb 19 2008

• By Emily Hayes

Related Content

FDA Anti-Infective Drugs Advisory Committee To Review Two Antibiotics

Jan 10 2008

Replidyne Restructures To Keep Orapem Program Afloat

Dec 11 2007

Forest’s Faropenem Is “Not Approvable”; Additional Studies Will Take Two Years

Oct 23 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window